Tag: biopharmaceuticals
CSL to buy majority stake in a leading Chinese plasma fractionator
Australian biotech firm CSL has agreed to acquire an 80% stake in China’s plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (Ruide) in...
Featured Article
Embracing the future: Australian manufacturing trends in 2025
As the calendar turns to 2025, the Australian manufacturing sector stands at the cusp of transformation.
